Peptomyc

We are pleased to announce that Peptomyc expands Patent Portfolio with European and Indian Patent Grant for its Methods and Composition for the Treatment of Cancer. https://shorturl.at/fhmvG

We are pleased to announce that #Peptomyc is at #Bio24 in San Diego! ➣Come and join us at the European Pavilion for an exciting journey of innovation, collaboration, and growth, alongside the group of 15 EIC-funded companies. Our CFO, Jörg Klumbis, and our CSO, Marie-Eve Beaulieu had the opportunity to take part in a B2B session with North American experts. They were invited for an exclusive tour alongside renowned EU vendors and manufacturers, providing us with valuable insights into the latest trends and innovations shaping the global biotech industry. #InnovationLeadership #EUFunded #TechExhibition #EUatBIO2024 #EUeic

👉Our CMO, Manuela Dr. med Niewel is at #ASCO24 ! Join her in Chicago, USA, at McCormick Place! https://shorturl.at/9QeD4

 ✔️Peptomyc is gearing up for the #biotech event of the year: #BIO24 with the #EUeic International Trade Fairs Programme 3.0! We are thrilled to be part of the 15 EIC-backed companies showcasing cutting-edge biotech solutions! Meet us at the European Pavilion! Lear more at ➡️ https://bit.ly/3QGyRSS #EUatBIO2024 🚀

Our CMO, Dr. Manuela Dr. med Niewel will be in Chicago, USA, from 31st May to 4th June. Meet her at #ASCO2024 ! https://shorturl.at/9QeD4

Yesterday 21st May, our CEO, Laura Soucek gave a talk at University of Oxford regarding the development of the first clinically viable MYC inhibitor. A special thanks to the organization and students who hosted her! https://shorturl.at/l3ilt

Peptomyc has been selected among 15 most innovative companies out of 68 EIC accelerator awardees to represent Europe in the #EuSoftLanding program. CSO, Marie-Eve Beaulieu and CFO, Jörg Klumbis are representing the company in this full week of training and learning about the US ecosystem in San Francisco. Thanks to the #Eueic and to Jillian Manus for organizing such a valuable program to build innovation bridges between Europe and the US. #PEPTOMYC #training

Our CSO, Marie-Eve Beaulieu presented at PEGS Boston Summit on 15th May 2024.

Today, Tuesday 21st May, Dr. Laura Soucek is presenting at "Oxford Talks" in University of Oxford. ➭ "Developing a viable MYC inhibitor for cancer treatment: a challenging journey from the lab to the clinic" https://rb.gy/a2virs

Last day in San Diego! Join Manuela Dr. med Niewel, our CMO, at #AACR24.